REQUEST FOR THE PROPOSAL No. 38/2021-ARG – Phase I, First-in-Human type, clinical trial

The order is carried out as a part of the project titled:
– ARG: „PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-415/17)

co-financed by the European Union Funds and carried out on the basis of the competitiveness principle

We hereby look for Contractor ready to perform: Organization and comprehensive execution of the phase I, First-in-Human type, clinical trial for a OATD-02 compound.

38_2021_Request_ENG

38_2021_Appendices_1_2_3_4_ENG

Kinga KazimierczakREQUEST FOR THE PROPOSAL No. 38/2021-ARG – Phase I, First-in-Human type, clinical trial